2m 2m 2m 2m 2m 2m 2m
Inhibrx Bio (INBX)
NASDAQ
$109.43+$0.16 (+0.15%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.6BMarket Cap
- 297.06%1-Year Change
- BiotechnologyIndustry
Inhibrx Bio (INBX)
$109.43+$0.16 (+0.15%)
INBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $109.27 | ||
Change | -$2.15 (-1.93%) | ||
Open | $113.00 | ||
High | $115.11 | ||
Low | $108.93 | ||
Previous Close | $111.42 | ||
Volume | 211,017 | ||
30-Day Average Volume | 360,088 | ||
1-Week Change | -9.82% | ||
1-Month Change | 18.28% | ||
1-Year Change | 297.06% | ||
3-Year Change | 434.59% | ||
5-Year Change | 220.53% | ||
Fundamentals | |||
Shares Outstanding | 14.7M | ||
Total Assets | $154.2M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$36.6M | ||
Free Cash Flow | -$29.9M | ||
EBIT | -$30.9M | ||
EBITDA | -$30.4M | ||
Net Working Capital | $114.1M | ||
EPS | -$2.34 | ||
Enterprise Value/EBITDA | -54 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -30 | ||
P/E | -47 | ||
PEG | 5 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue